Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Neurocomputing (Amst). 2011 Dec 31;84:47–52. doi: 10.1016/j.neucom.2011.12.020

Fig. 6.

Fig. 6

Arthritic vs. Arthritic Treated with Ketorolac: Nocturnal Activity (Normalized). Significance values above the bracket were obtained with a Kruskal-Wallis test (nonparametric ANOVA), significance values for each bar were obtained with a Dunn’s Multiple Comparison Test (controlled for test-wide error rate). Significant difference in means was observed for nights 6–12. Note that although drug administration was stopped on day 9 (night 8), there is significant difference in activity through night 12.